Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

P Starlinger

Showing results (101-110 of 112) with videos related to

Pageof 12
Sort By:
Annals of Surgical Oncology|May 8, 2024
Neuroendocrine Tumors of Unknown Primary in the Setting of Cytoreductive HepatectomyMarkus Ammann, Hallbera Gudmundsdottir, Hubert Hackl, et al.
Blood|June 11, 2026
Anti-fibrinolytic strategies improve liver regeneration in mice and reduce post-hepatectomy liver failure in patientsZhihao Li, Zimu Wei, Dafna J Groeneveld, et al.
European Journal of Surgical Oncology : the Journal of the European Society of Surgical Oncology and the British Association of Surgical Oncology|November 23, 2024
Surgical and oncologic outcomes for liver resections of cystic neuroendocrine tumor liver metastasisMarkus Ammann, Stella K Adjei Antwi, Hallbera Gudmundsdottir, et al.
HPB : the Official Journal of the International Hepato Pancreato Biliary Association|July 2, 2022
Patency rates of hepatic arterial resection and revascularization in locally advanced pancreatic cancerRoberto Alva-Ruiz, Amro M Abdelrahman, Patrick P Starlinger, et al.
Cancers|July 13, 2024
Circulating Tumor DNA Predicts Early Recurrence Following Locoregional Therapy for Oligometastatic Colorectal CancerConor D J O'Donnell, Nikolas Naleid, Teerada Siripoon, et al.
Journal of Neuroendocrinology|June 30, 2026
Outcomes of liver resections for neuroendocrine tumor liver metastases in carcinoid heart diseaseMarkus Ammann, Hallbera Gudmundsdottir, Vanja Podrascanin, et al.
Journal of the National Comprehensive Cancer Network : JNCCN|February 11, 2026
Redefining Upfront Resectable Pancreatic Ductal Adenocarcinoma: Should Vein Abutment Matter?Po Hong Tan, Cornelius A Thiels, Katherine Poruk, et al.
Annals of Surgical Oncology|April 10, 2025
ASO Visual Abstract: Molecular KRAS ctDNA Predicts Metastases and Survival in Pancreatic Cancer-A Prospective Cohort StudyJennifer L Leiting, Roberto Alva-Ruiz, Jennifer A Yonkus, et al.
Annals of Surgical Oncology|March 11, 2025
Molecular KRAS ctDNA Predicts Metastases and Survival in Pancreatic Cancer: A Prospective Cohort StudyJennifer L Leiting, Roberto Alva-Ruiz, Jennifer A Yonkus, et al.
Journal of Surgical Oncology|June 2, 2026
Enhanced Molecular Staging of Pancreatic Cancer Using Methylated DNA Markers in Peritoneal Lavage FluidKrystal Mills, Calise K Berger, William R Taylor, et al.
Pageof 12

Showing results (101-110 of 112) with videos related to

Sort By:
Pageof 12
Annals of Surgical Oncology|May 8, 2024
Neuroendocrine Tumors of Unknown Primary in the Setting of Cytoreductive HepatectomyMarkus Ammann, Hallbera Gudmundsdottir, Hubert Hackl, et al.
Blood|June 11, 2026
Anti-fibrinolytic strategies improve liver regeneration in mice and reduce post-hepatectomy liver failure in patientsZhihao Li, Zimu Wei, Dafna J Groeneveld, et al.
European Journal of Surgical Oncology : the Journal of the European Society of Surgical Oncology and the British Association of Surgical Oncology|November 23, 2024
Surgical and oncologic outcomes for liver resections of cystic neuroendocrine tumor liver metastasisMarkus Ammann, Stella K Adjei Antwi, Hallbera Gudmundsdottir, et al.
HPB : the Official Journal of the International Hepato Pancreato Biliary Association|July 2, 2022
Patency rates of hepatic arterial resection and revascularization in locally advanced pancreatic cancerRoberto Alva-Ruiz, Amro M Abdelrahman, Patrick P Starlinger, et al.
Cancers|July 13, 2024
Circulating Tumor DNA Predicts Early Recurrence Following Locoregional Therapy for Oligometastatic Colorectal CancerConor D J O'Donnell, Nikolas Naleid, Teerada Siripoon, et al.
Journal of Neuroendocrinology|June 30, 2026
Outcomes of liver resections for neuroendocrine tumor liver metastases in carcinoid heart diseaseMarkus Ammann, Hallbera Gudmundsdottir, Vanja Podrascanin, et al.
Journal of the National Comprehensive Cancer Network : JNCCN|February 11, 2026
Redefining Upfront Resectable Pancreatic Ductal Adenocarcinoma: Should Vein Abutment Matter?Po Hong Tan, Cornelius A Thiels, Katherine Poruk, et al.
Annals of Surgical Oncology|April 10, 2025
ASO Visual Abstract: Molecular KRAS ctDNA Predicts Metastases and Survival in Pancreatic Cancer-A Prospective Cohort StudyJennifer L Leiting, Roberto Alva-Ruiz, Jennifer A Yonkus, et al.
Annals of Surgical Oncology|March 11, 2025
Molecular KRAS ctDNA Predicts Metastases and Survival in Pancreatic Cancer: A Prospective Cohort StudyJennifer L Leiting, Roberto Alva-Ruiz, Jennifer A Yonkus, et al.
Journal of Surgical Oncology|June 2, 2026
Enhanced Molecular Staging of Pancreatic Cancer Using Methylated DNA Markers in Peritoneal Lavage FluidKrystal Mills, Calise K Berger, William R Taylor, et al.
Pageof 12